Aeglea BioTherapeutics
regulatory and program status | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
23 of 39
Related slides by other companies
9 Meters Biopharma
Investor Presentation
September 2022
clinical regulatory next steps | 9 Meters Biopharma
Absci
Investor Presentation
October 2023
we are leveraging our platform advantages to create internal programs | Absci
Chimerix
Mergers and Acquisitions
January 2021
key regulatory communications potential path to approval | Chimerix
Adagio Therapeutics
Results
November 2023
commercialization preparations are underway for potential launch in the if authorized | Adagio Therapeutics
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io